<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCS</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="epub">2164-3202</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcs.2023.135009</article-id><article-id pub-id-type="publisher-id">WJCS-125150</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Primary Cardiac Tumors Operated on in C&#244;te d’Ivoire: They Are Almost All Myxomas
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoboua</surname><given-names>Aimé Kirioua-Kamenan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>Calaire Degré</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Koutoua</surname><given-names>Eric Katché Katché</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kouassi</surname><given-names>Antonin Souaga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kwadjau</surname><given-names>Anderson Amani</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Assoumou</surname><given-names>Lucien Asseke</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahim</surname><given-names>Junior Yeo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Landry</surname><given-names>Kohou-Kone</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kouassi</surname><given-names>Flavien Kendja</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Thoracic Surgery Department, Abidjan Heart Institute, Abidjan, C&amp;amp;#244te d’Ivoire</addr-line></aff><aff id="aff2"><addr-line>Department of Surgery and Surgical Specialties, F&amp;amp;#233lix Houphou&amp;amp;#235t-Boigny University, Abidjan, C&amp;amp;#244te d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Cardiovascular Surgery Department, Abidjan Heart Institute, Abidjan, C&amp;amp;#244te d’Ivoire</addr-line></aff><aff id="aff4"><addr-line>Anesthesia and Intensive Care Department, Abidjan Heart Institute, Abidjan, C&amp;amp;#244te d’Ivoire</addr-line></aff><pub-date pub-type="epub"><day>25</day><month>05</month><year>2023</year></pub-date><volume>13</volume><issue>05</issue><fpage>93</fpage><lpage>99</lpage><history><date date-type="received"><day>11,</day>	<month>April</month>	<year>2023</year></date><date date-type="rev-recd"><day>23,</day>	<month>May</month>	<year>2023</year>	</date><date date-type="accepted"><day>26,</day>	<month>May</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Objective:</b>
   Through this surgical series, we present the epidemiological and anatomical-clinical aspects and the surgical results concerning patients operated on for a primary cardiac tumor at the Abidjan Heart Institute.
   
  <b>Materials and Method:</b>
  <b> </b>
  This is a retrospective descriptive study covering the period of January 1982 to December 2022, based on the medical records of patients operated on for a primary cardiac tumor at the Abidjan Heart Institute
  . 
  <b>Results</b>
  : Twenty-seven (27) patients underwent surgery for a primary cardiac tumor, including 14 women and 13 men with a mean age of 41.5 years (range 19
   
  -
   
  76 years). The main circumstances of discovery were exertional dyspnea, palpitation and syncope or pseudo-syncope. The main site was the septal wall of the left atrium. The diagnosis of myxoma was confirmed by pathological examination of the surgical specimen in 96.3% (n
   
  =
   
  24) of the patients and it was a malignant large cell immunoblastic lymphoma of the myocardium in 3.7% (n
   
  =
   
  1) of the patients. The mean largest diameter was 46.1
   
  mm. The postoperative course was marked by an ischaemic stroke (n
   
  =
   
  1); recurrence of a left atrial myxoma 5 years after the first tumor removal (n
   
  =
   
  1).
   
  Two cases of death were noted, one due to the evolution of immunoblastic large cell lymphoma and the other due to an extracorporeal circulation accident.
   
  <b>Conclusion</b>
  : Almost all primary cardiac tumors operated on in Abidjan are myxomas. The circumstances of 
  the 
  discovery of these cardiac tumors are multiple and varied but dominated by exertional dyspnea, palpitation and syncope. Whatever their histological type, primary cardiac tumors are serious affections, in view of the haemodynamic and rhythmic disorders they cause.
 
</p></abstract><kwd-group><kwd>Cardiac Myxomas</kwd><kwd> Primary Cardiac Tumors</kwd><kwd> Tumor Removal</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cardiac tumors are benign or malignant neoformations that affect the epicardium, myocardium, endocardium and valves [<xref ref-type="bibr" rid="scirp.125150-ref1">1</xref>] . Malignant cardiac tumors can be primary or secondary [<xref ref-type="bibr" rid="scirp.125150-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref3">3</xref>] . Three-quarters of primary cardiac tumors are benign and the majority of benign tumors are myxomas [<xref ref-type="bibr" rid="scirp.125150-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref6">6</xref>] . Primary malignant cardiac tumors are even rarer. They can be sarcomas, mesotheliomas, or lymphomas [<xref ref-type="bibr" rid="scirp.125150-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref8">8</xref>] . In C&#244;te d’Ivoire, a government policy of installing a medical cardiology service in each regional hospital was initiated a decade ago. This policy contributes to the improvement of the diagnosis of heart disease and therefore of cardiac tumors. Although still rare, the incidence of cardiac tumors is clearly increasing because they are probably better diagnosed.</p><p>Through this surgical series, we present the epidemiological and anatomical-clinical aspects and the surgical results concerning patients operated on for a primary cardiac tumor at the Abidjan Heart Institute.</p></sec><sec id="s2"><title>2. Materials and Method</title><p>This is a retrospective descriptive study covering the period of January 1982 to December 2022, based on the medical records of patients successively operated on for a primary cardiac tumor at the Abidjan Heart Institute. Excluded from this study were three suspected cases of primary benign cardiac tumor who were not operated on before they were lost to follow-up and one case of right intra-auricular metastasis of papillary adenocarcinoma of the thyroid gland, because it was not a primary tumor of the heart. Data entry and analysis were performed by MICROSOFT WORD 2007, EXCEL 2007 and INFINIX HOT 5 LITE software. The parameters studied included: socio-demographic data, the circumstances of discovery, tumor site and measurements on Cardiac Echography and/or Magnetic Resonance Imaging, The cardiac tumor approaches after sternotomy, peri-operative complications, the result of the anatomo-pathological examination of the surgical specimen and the clinical and ultrasound data from short, medium and long terms postoperative follow-up. The quantitative parameters were expressed in averages with their extremes and the qualitative parameters in numbers with their percentages.</p></sec><sec id="s3"><title>3. Results</title><p>Twenty-seven patients, operated on for a primary cardiac tumor, were collected. 14 were women and 13 were men with a mean age of 41.5 years (range 19 - 76 years). The circumstances of discovery are grouped in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>All patients (n = 27) received cardiac echography (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). In addition, 02 patients received magnetic resonance imaging (see <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Circumstances of discovery</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Circumstances of discovery</th><th align="center" valign="middle" >Numbers</th><th align="center" valign="middle" >Percentages</th></tr></thead><tr><td align="center" valign="middle" >exertional dyspnea</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >40.7</td></tr><tr><td align="center" valign="middle" >Palpitation</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >14.8</td></tr><tr><td align="center" valign="middle" >Syncope or Pseudo-syncope</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >11.0</td></tr><tr><td align="center" valign="middle" >Decubitus Vertigo</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Myocardial infarction</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Constituted ischaemic stroke</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.4</td></tr><tr><td align="center" valign="middle" >Transient Ischaemic Attack</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Global heart failure</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.4</td></tr><tr><td align="center" valign="middle" >Lower limb oedema</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Incidental discovery</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>The cardiac topography of these tumors is shown in <xref ref-type="table" rid="table2">Table 2</xref>. In terms of measurements, the average of the largest diameters was 46.1 mm (range 8 - 88 mm). The cardiac tumor approaches are shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>Complete tumor removal was performed in 96.3% (n = 26) of patients (see <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>A biopsy of the right ventricular free muscle wall tumor was performed in 3.70% (n = 1) of patients. Pathological examination of the surgical specimen confirmed the diagnosis of myxoma in 96.30% (n = 26) of patients and the diagnostic of myocardial immunoblastic large cell lymphoma in 3.70% (n = 1) of patients.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Topography of cardiac tumors</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Heart cavities Topography</th><th align="center" valign="middle" >Left atrium</th><th align="center" valign="middle" >Left ventricle</th><th align="center" valign="middle" >Right atrim</th><th align="center" valign="middle" >Right ventricle</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >Free wall</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >Septal wall</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Atrio-ventricular valve (atrial or ventricular side)</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >27</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Cardiac tumor approaches</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Cardiac tumor approaches</th><th align="center" valign="middle" >Numbers</th><th align="center" valign="middle" >Percentages</th></tr></thead><tr><td align="center" valign="middle" >Trans-septal</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >55.56</td></tr><tr><td align="center" valign="middle" >Left atriotomy</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >22.22</td></tr><tr><td align="center" valign="middle" >Right atriotomy</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >18.52</td></tr><tr><td align="center" valign="middle" >Right ventricle</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.70</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>The surgical results were as follows: Postoperative morbidity was represented by Ischaemic stroke (n = 1) which regressed with minimal sequel of left mono paresis; and the recurrence of a left atrial myxoma 5 years after the first tumor removal (n = 1) which was successfully reoperated. Two deaths were noted, one due to the terminal course of immunoblastic large cell malignant lymphoma and the other due to a major failure of the cardiotomy reservoir during extracorporeal circulation.</p></sec><sec id="s4"><title>4. Discussion</title><p>Medical literature has established that three quarters of primary cardiac tumors are benign and the majority of benign tumors are myxomas [<xref ref-type="bibr" rid="scirp.125150-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref6">6</xref>] . This predominance of myxomas is found in our study (96.3%). All the cases of myxoma in this series are intra-atrial, althoughother locations like ventricular myxoma and anterior mitral valve leaflet have been described in the literature [<xref ref-type="bibr" rid="scirp.125150-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref11">11</xref>] .</p><p>Primary malignant cardiac tumors are extremely rare. They represent 0.018% of cases observed in the autopsy series of Butany J et al. [<xref ref-type="bibr" rid="scirp.125150-ref12">12</xref>] ; they constitute 25% of primary cardiac tumors and are dominated by sarcomas and malignant lymphomas [<xref ref-type="bibr" rid="scirp.125150-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref13">13</xref>] . Indeed, the only case of primary malignant cardiac tumor in our series was a malignant immunoblastic large cell lymphoma. Unlike other primary malignant tumors, lymphomas are generally sensitive to chemotherapy and radiotherapy [<xref ref-type="bibr" rid="scirp.125150-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref13">13</xref>] . Tumor fragments or peri-tumor thrombi may embolise into the systemic circulation [<xref ref-type="bibr" rid="scirp.125150-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref15">15</xref>] . This serious complication was the circumstance of discovery in three patients of our series. In addition, autopsy findings of cardiac tumors, including asymptomatic right atrial myxoma, leading to massive and fatal pulmonary embolism have been described [<xref ref-type="bibr" rid="scirp.125150-ref16">16</xref>] . Nevertheless, pulmonary embolism was not the circumstance of discovery of any of the 05 right intra-atrial locations in this series. In addition, only one case of an asymptomatic form of cardiac tumor, discovered incidentally during a health check-up, was noted in this short series. The circumstances of discovery therefore show that cardiac tumors end up being symptomatic in the majority of cases.</p><p>In practice, the etiological approach to a mass suspected of being a cardiac tumor is based on transthoracic and transesophageal echocardiography [<xref ref-type="bibr" rid="scirp.125150-ref17">17</xref>] . This allows the diagnosis of a tumor to be confirmed or invalidated by eliminating a constructed image, a false echo, an anatomical variant, a cyst or a thrombus. Echocardiography also specifies the exact location, extension and dimensions of the mass and the haemodynamic impact. If the echographic appearance is not very suggestive of a benign tumor, Magnetic Resonance Imaging plays a major role in confirming the tissue nature of the mass, eliminating a thrombus and confirming the diagnosis of a cardiac tumor [<xref ref-type="bibr" rid="scirp.125150-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.125150-ref19">19</xref>] . However, Magnetic Resonance Imaging is a recent examination in our environment and its high cost at present limits its popularisation in daily practice. We only used Magnetic Resonance Imaging in 2 patients. In case of doubt about the benign or malignant nature of a cardiac tumor, imaging-guided endomyocardial biopsies are essential. Indeed, only the anatomo-pathological analysis of the biopsy or the excisional specimen can confirm the benign or malignant nature of a cardiac tumor [<xref ref-type="bibr" rid="scirp.125150-ref20">20</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Almost all primary cardiac tumors operated on in Abidjan are myxomas. The circumstances of the discovery of these cardiac tumors are multiple and varied but dominated by exertional dyspnea, palpitation and syncope. Whatever their histological type is, primary cardiac tumors are serious affections, in view of the haemodynamic and rhythmic disorders they cause.</p></sec><sec id="s6"><title>Limits of the Study</title><p>The retrospective nature and the small size of the population studied constitute the main limitations of our study.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Kirioua-Kamenan, Y.A., Degr&#233;, J.C., Katch&#233;, K.E., Souaga, K.A., Amani, K.A., Asseke, A.L., Yeo, I.J., Kohou-Kone, L. and Kendja, K.F. (2023) Primary Cardiac Tumors Operated on in C&#244;te d’Ivoire: They Are Almost All Myxomas. World Journal of Cardiovascular Surgery, 13, 93-99. https://doi.org/10.4236/wjcs.2023.135009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.125150-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Rahouma, M., Arisha, M.J., Elmously, A., El-Sayed Ahmed, M.M., Spadaccio, C., Mehta, K., et al. (2020) Cardiac Tumors Prevalence and Mortality: A Systematic Review and Meta-Analysis. International Journal of Surgery, 76, 178-189. https://doi.org/10.1016/j.ijsu.2020.02.039</mixed-citation></ref><ref id="scirp.125150-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Castello, J. and Silvay, G. (2010) Characterization and Management of Cardiac Tumors. Seminars in Cardiothoracic and Vascular Anesthesia, 14, 6-20. https://doi.org/10.1177/1089253210362596</mixed-citation></ref><ref id="scirp.125150-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Burazor, I., Aviel-Ronen, S., Imazio, M., Markel, G., Grossman, Y., Yosepovich, A., et al. (2014) Primary Malignancies of the Heart and Pericardium. Clinical Cardiology, 37, 582-588. https://doi.org/10.1002/clc.22295</mixed-citation></ref><ref id="scirp.125150-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Reynen, K. (1995) Medical Progress: Cardiac Myxomas. New England Journal of Medicine, 333, 1610-1617. https://doi.org/10.1056/NEJM199512143332407</mixed-citation></ref><ref id="scirp.125150-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Elbardissi, A.W., Dearani, J.A., Daly, R.C., Mullany, C.J., Orszulak, T.A., Puga, F.J., et al. (2008) Survival after Resection of Primary Cardiac Tumors: A 48-Year Experience. Circulation, 118, S7-S15. https://doi.org/10.1161/CIRCULATIONAHA.107.783126</mixed-citation></ref><ref id="scirp.125150-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Khakural, P., Baral, R., Bhattarai, A. and Koirala, B. (2022) Cardiac Myxoma among Patients Undergoing Cardiac Surgery in a Tertiary Care Center: A Descriptive Cross-Sectional Study. Journal of Nepal Medical Association, 60, 111-115. https://doi.org/10.31729/jnma.6538</mixed-citation></ref><ref id="scirp.125150-ref7"><label>7</label><mixed-citation publication-type="book" xlink:type="simple">Reardon, M.J. and Smythe, W.R. (2003) Cardiac Neoplasms. In: Cohn, L.H. and Edmunds Jr., L.H., Eds., Cardiac Surgery in the Adult, McGraw-Hill, New York, 1373-400.</mixed-citation></ref><ref id="scirp.125150-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Lam, K.Y., Dickens, P. and Chan, A.C. (1993) Tumors of the Heart. A 20-Year Experience with a Review of 12,485 Consecutive Autopsies. Archives of Pathology and Laboratory Medicine, 117, 1027-1031.</mixed-citation></ref><ref id="scirp.125150-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Yoon, J.-H., Kim, J.-H., Sung, Y.-J., Lee, M.-H., Cha, M.-J., Kang, D.-Y., Kim, Y.-J. and Ahn H (2011) Cardiac Myxoma Originating from the Anterior Mitral Valve Leaflet. Journal of Cardiovascular Ultrasound, 19, 228-231. https://doi.org/10.4250/jcu.2011.19.4.228</mixed-citation></ref><ref id="scirp.125150-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Bouferrouk, A. and Boutamine, S. (2011) Left Ventricular Myxoma. Sang Thrombose Vaisseaux, 23, 317-319.</mixed-citation></ref><ref id="scirp.125150-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Francois, J., Kupferstein, E., Abdul, R., Casillas, J., Ibtida, I., Salifu, M. and McFarlane, S.I. (2020) Asymptomatic Patient with an Uncommonly Located Myxoma in the Left Ventricle Attached to Chordae Tendinae. American Journal of Medical Case Reports, 8, 313-314. https://doi.org/10.12691/ajmcr-8-9-14</mixed-citation></ref><ref id="scirp.125150-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Butany, J., Leong, S.W., Carmichael, K. and Komeda, M. (2005) A 30-Year Analysis of Cardiac Neoplasms at Autopsy. Canadian Journal of Cardiology, 21, 675-680.</mixed-citation></ref><ref id="scirp.125150-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Butany, J., Nair, V., Naseemuddin, A., Nair, G.M., Catton, C. and Yau, T. (2005) Cardiac Tumors: Diagnosis and Management. Lancet Oncology, 6, 219-28. https://doi.org/10.1016/S1470-2045(05)70093-0</mixed-citation></ref><ref id="scirp.125150-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Yilmaz, M., Gurlertop, Y., Kocaturk, H., Karakelleoglu, S. and Kocak, H. (2004) Unusually Large Left Atrial Myxoma Presenting with Severe Mitral Valve Obstruction Symptoms. Echocardiography, 21, 145-148. https://doi.org/10.1111/j.0742-2822.2004.03089.x</mixed-citation></ref><ref id="scirp.125150-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Saaf, S., Miqdadi, A., Merzouk, F.-Z., El Aidaoui, K. and Hazim, A. (2022) Cardiac Myxoma as a Rare Cause of an Ischemic Stroke of the Vertebrobasilar Territory in a Young Adult: A Case Report. Cureus, 14, e24792. https://doi.org/10.7759/cureus.24792</mixed-citation></ref><ref id="scirp.125150-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sato, H., Tanaka, T., Kasai, K., Kita, T. and Tanaka, N. (2008) Sudden Death Due to Acute Pulmonary Embolism from Asymptomatic Right Atrial Myxoma. Journal of Forensic Legal Medicine, 2, 10-13. https://doi.org/10.1016/j.jflm.2008.02.013</mixed-citation></ref><ref id="scirp.125150-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ragland, M.M. and Tak, T. (2006) The Role of Echocardiography in Diagnosing Space-Occupying Lesions of the Heart. Clinical Medicine and Research, 4, 22-32. https://doi.org/10.3121/cmr.4.1.22</mixed-citation></ref><ref id="scirp.125150-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Luna, A., Ribes, R., Caro, P., Vida, J. and Erasmus, J.J. (2005) Evaluation of Cardiac Tumors with Magnetic Resonance Imaging. European Radiology, 15, 1446-1455. https://doi.org/10.1007/s00330-004-2603-y</mixed-citation></ref><ref id="scirp.125150-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Shenoy, C., Grizzard, J.D., Shah, D.J., Kassi, M., Reardon, M.J., Zagurovskaya, M., Kim, H.W., Parker, M.A. and Kim, R.J. (2021) Cardiovascular Magnetic Resonance Imaging in Suspected Cardiac Tumor: A Multicentre Outcomes Study. European Heart Journal, 43, 71-80. https://doi.org/10.1093/eurheartj/ehab635</mixed-citation></ref><ref id="scirp.125150-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Altbach, M.I., Squire, S.W., Kudi-Thipudi, V., Castellano, L. and Sorrell, V.L. (2007) Cardiac MRI Is Complementary to Echocardiography in the Assessment of Cardiac Masses. Echocardiography, 24, 286-300. https://doi.org/10.1111/j.1540-8175.2007.00392.x</mixed-citation></ref></ref-list></back></article>